Christelle Dousset

1.6k total citations
25 papers, 990 citations indexed

About

Christelle Dousset is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Christelle Dousset has authored 25 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Christelle Dousset's work include Lymphoma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Christelle Dousset is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Christelle Dousset collaborates with scholars based in France, United States and Tunisia. Christelle Dousset's co-authors include Danila Valmori, Gilles Bioley, Maha Ayyoub, Lucie Leveque, Isabelle Raimbaud, Florence Deknuydt, Catherine Pellat‐Deceunynck, Martine Amiot, Steven Le Gouill and Cyrille Touzeau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Christelle Dousset

23 papers receiving 983 citations

Peers

Christelle Dousset
Mark W. Brunvand United States
Ingrid A. M. Derks Netherlands
Matt Teater United States
Bruce R. Rowley United States
Christelle Dousset
Citations per year, relative to Christelle Dousset Christelle Dousset (= 1×) peers Keisuke Horikawa

Countries citing papers authored by Christelle Dousset

Since Specialization
Citations

This map shows the geographic impact of Christelle Dousset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christelle Dousset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christelle Dousset more than expected).

Fields of papers citing papers by Christelle Dousset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christelle Dousset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christelle Dousset. The network helps show where Christelle Dousset may publish in the future.

Co-authorship network of co-authors of Christelle Dousset

This figure shows the co-authorship network connecting the top 25 collaborators of Christelle Dousset. A scholar is included among the top collaborators of Christelle Dousset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christelle Dousset. Christelle Dousset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2026). CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival. Leukemia.
2.
Maïga, Sophie, Christelle Dousset, Agnès Moreau‐Aubry, et al.. (2025). VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target. Leukemia. 39(4). 995–1000.
3.
Bellanger, Céline, Benoît Tessoulin, Christelle Dousset, et al.. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. 109(8). 2574–2584. 1 indexed citations
4.
Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations
5.
Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations
6.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2022). The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition. Haematologica. 107(12). 2905–2917. 12 indexed citations
7.
Tessoulin, Benoît, Géraldine Descamps, Christelle Dousset, Martine Amiot, & Catherine Pellat‐Deceunynck. (2019). Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells. Frontiers in Oncology. 9. 128–128. 24 indexed citations
9.
Chiron, David, Christelle Dousset, Carole Brosseau, et al.. (2015). Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma. Oncotarget. 6(11). 8750–8759. 65 indexed citations
10.
Brosseau, Carole, Christelle Dousset, Cyrille Touzeau, et al.. (2014). Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. Cell Death and Disease. 5(8). e1389–e1389. 7 indexed citations
11.
Touzeau, Cyrille, Carole Brosseau, Christelle Dousset, et al.. (2013). Mantle-Cell Lymphoma (MCL) Cells Are Highly Sensitive To ABT-199 But Their Sensitivity May Be Altered By The Microenvironment Via The Up-Regulation Of Bcl-Xl and Bcl2A1. Blood. 122(21). 4285–4285. 2 indexed citations
12.
Péterlin, Pierre, Christophe Leux, Thomas Gastinne, et al.. (2012). Is ASCT With TBI Superior to ASCT Without TBI in Mantle Cell Lymphoma Patients?. Transplantation. 94(3). 295–301. 10 indexed citations
13.
Touzeau, Cyrille, Christelle Dousset, Patricia Gomez‐Bougie, et al.. (2011). ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells with a Bcl-2 high /Mcl-1 low Profile and Synergizes with Other Antineoplastic Agents. Clinical Cancer Research. 17(18). 5973–5981. 49 indexed citations
14.
Gomez‐Bougie, Patricia, Emmanuelle Ménoret, Philippe Juin, et al.. (2011). Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction. Biochemical and Biophysical Research Communications. 413(3). 460–464. 78 indexed citations
15.
Gomez‐Bougie, Patricia, Cyrille Touzeau, Christelle Dousset, et al.. (2011). ABT-737 is highly effective against molecular subgroups of multiple myeloma. Blood. 118(14). 3901–3910. 95 indexed citations
16.
Touzeau, Cyrille, Christelle Dousset, Stéphanie Bonnaud, et al.. (2010). Rational for the Use of a Targeted-Therapy Using ABT-737 In Mantle-Cell Lymphoma. Blood. 116(21). 770–770. 4 indexed citations
17.
Ayyoub, Maha, Florence Deknuydt, Isabelle Raimbaud, et al.. (2009). Human memory FOXP3+ Treg secrete IL-17 ex-vivo and constitutively express the TH17 lineage specific transcription factor ROR{gamma}t. The Journal of Immunology. 182. 110 indexed citations
18.
Devilder, Marie‐Claire, Sophie Allain‐Maillet, Christelle Dousset, Marc Bonneville, & Emmanuel Scotet. (2009). Early Triggering of Exclusive IFN-γ Responses of Human Vγ9Vδ2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells. The Journal of Immunology. 183(6). 3625–3633. 68 indexed citations
19.
Trichet, Valérie, C Bénézech, Christelle Dousset, et al.. (2006). Complex Interplay of Activating and Inhibitory Signals Received by Vγ9Vδ2 T Cells Revealed by Target Cell β2-Microglobulin Knockdown. The Journal of Immunology. 177(9). 6129–6136. 21 indexed citations
20.
Dousset, Christelle, et al.. (2005). AP2 Clathrin Adaptor Complex, but Not AP1, Controls the Access of the Major Histocompatibility Complex (MHC) Class II to Endosomes. Journal of Biological Chemistry. 280(20). 19656–19664. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026